For decades, ankylosing spondylitis was considered a man’s disease, but new research reveals something shocking: ankylosing spondylitis hits women differently and nearly as frequently as men, yet ...

Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints (those between the spine and hipbone). Less commonly, AS can affect other joints such ...

Ivarmacitinib, a highly selective Janus kinase 1 (JAK1) inhibitor, tamed ankylosing spondylitis with sustained efficacy through 24 weeks in a phase 2/3 trial. A phase 2/3 trial in China evaluated the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. There were no new safety signals, while all fungal ...

Ankylosing spondylitis (AS), a type of arthritis that affects joints, tendons, and ligaments in the lower back and the base of the spine, can make you feel as if your energy has been zapped. It’s a ...

Patients with ankylosing spondylitis who were exposed to tumor necrosis factor (TNF) inhibitors had an approximately 30% lower risk for cardiovascular events than those who had never been exposed to ...

Ankylosing spondylitis (AS) is a chronic inflammatory disorder that predominantly affects the axial skeleton, leading to progressive spinal fusion and reduced flexibility. The resultant rigidity of ...

(RTTNews) - UCB announced new long-term data from the Bimzelx (bimekizumab) Phase 2b study BE AGILE and its open-label extension. Patients with ankylosing spondylitis treated with Bimzelx, an IL-17A ...